Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To examine whether the mean change from baseline in HbA1c with co-administered saxagliptin 5 mg and dapagliflozin 10 mg plus metformin with or without SU is non-inferior to titrated insulin glargine plus metformin with or without SU after 24 weeks of open-label treatment.
Critère d'inclusion
- Type 2 diabetes mellitus and inadequate glycemic control on a stable dose of metformin